Presenter SpeechJessica Fye Great. Welcome, everyone. My name is Jess Fye. I m a senior biotech analyst at JPMorgan, and we re continuing the health care conference today with Esperion. I m joined.
Stock Traders Buy High Volume of Esperion Therapeutics Call Options (NASDAQ:ESPR) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Stock traders acquired 12,186 call options on the stock. This represents an increase of approximately 620% compared to the average volume of 1,692 call options. Esperion Therapeutics Price Performance Esperion Therapeutics stock opened at $2.30 on […]
Daiichi Sankyo Europe GmbH: Esperion and Daiichi Sankyo Europe Announce $125 Million Amendment to Their Collaboration, Including Resolution of Pending Litigation finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.